The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 3,788 | 101,500 | SH | SOLE | 101,500 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS | COM | 00847X104 | 8,677 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| ARATANA THERAPEUTICS INC | COM | 03874P101 | 2,574 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| ARDELYX | COM | 039697107 | 3,920 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| ARQULE INC | COM | 04269E107 | 1,354 | 1,220,000 | SH | SOLE | 1,220,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 5,041 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 38,119 | 1,970,000 | SH | SOLE | 1,970,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 280 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES | COM | 09627Y109 | 51,207 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 7,365 | 1,403,000 | SH | SOLE | 1,403,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 11,309 | 1,700,600 | SH | SOLE | 1,700,600 | 0 | 0 | ||
| CORIUM INTERNATIONAL INC | COM | 21887L107 | 10,193 | 920,000 | SH | SOLE | 920,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 5,356 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 8,176 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | COM | 24344T101 | 4,120 | 217,000 | SH | SOLE | 217,000 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 7,753 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 4,680 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 19,368 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 6,338 | 1,142,000 | SH | SOLE | 1,142,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 12,565 | 898,800 | SH | SOLE | 898,800 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 3,207 | 1,802,000 | SH | SOLE | 1,802,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 3,745 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 1,648 | 28,400 | SH | SOLE | 28,400 | 0 | 0 | ||
| LOXO ONCOLOGY | COM | 548862101 | 11,975 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| SELECTA BIOSCIENCES INC | COM | 816212104 | 1,733 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| SYNLOGIC INC | COM | 87166L100 | 4,753 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 9,250 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| NEURODERM LTD | ORD SHS | M74231107 | 2,723 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| QUOTIENT TECHNOLOGY INC | COM | 749119103 | 542 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 8,700 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 8,142 | 1,180,000 | SH | SOLE | 1,180,000 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 1,716 | 116,574 | SH | SOLE | 116,574 | 0 | 0 | ||
| THERAVANCE BIOPHARMA INC | COM | G8807B106 | 6,163 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 6,292 | 320,200 | SH | SOLE | 320,200 | 0 | 0 | ||